• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

母血循环中游离胎儿核酸识别标志物

Cell-free Fetal Nucleic Acid Identifier Markers in Maternal Circulation.

作者信息

Ramezanzadeh Mahboubeh, Khosravi Sharifeh, Salehi Rasoul

机构信息

Department of Genetics and Molecular Medicine, School of Medicine, Bushehr University of Medical Sciences, Bushehr 751463341, Iran.

Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan 81744-176, Iran.

出版信息

Adv Biomed Res. 2017 Jul 28;6:89. doi: 10.4103/2277-9175.211800. eCollection 2017.

DOI:10.4103/2277-9175.211800
PMID:28828340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5549546/
Abstract

From the discovery of cell-free fetal (cff)-DNA in 1997 so far, many studies have been performed on various aspects of cff-nucleic acid. It is undoubted that currently, invasive prenatal diagnosis progresses to the noninvasive test. However, there are many problems. One of the most challenging issues in this field is differentiation and detection of the small amount of cff-nucleic acid in maternal plasma. Many markers and methods have been used for this purpose. This review makes an attempt to review and compare the studies in the field. Six identifier markers including Y-specific sequence, polymorphisms, epigenetic difference, DNA size difference, fetal mRNA, and microRNA as well as the advantages and disadvantages of each marker are discussed. This review provides a relatively perfect set on cff-nucleic acid biomarkers in various physiological and pathological status of pregnancy, helping to review and compare the prior obtained results, and improving designation in future studies.

摘要

自1997年发现游离胎儿(cff)-DNA以来,针对cff-核酸的各个方面已经开展了许多研究。毫无疑问,目前侵入性产前诊断正在向非侵入性检测发展。然而,存在许多问题。该领域最具挑战性的问题之一是母血中少量cff-核酸的鉴别和检测。为此已经使用了许多标志物和方法。本综述试图对该领域的研究进行回顾和比较。讨论了包括Y特异性序列、多态性、表观遗传差异、DNA大小差异、胎儿mRNA和微小RNA在内的六种识别标志物以及每种标志物的优缺点。本综述提供了一套关于妊娠各种生理和病理状态下cff-核酸生物标志物的相对完善的内容,有助于回顾和比较先前获得的结果,并改进未来研究中的设计。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce42/5549546/8dc500a36b04/ABR-6-89-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce42/5549546/c91aab45af71/ABR-6-89-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce42/5549546/8dc500a36b04/ABR-6-89-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce42/5549546/c91aab45af71/ABR-6-89-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce42/5549546/8dc500a36b04/ABR-6-89-g007.jpg

相似文献

1
Cell-free Fetal Nucleic Acid Identifier Markers in Maternal Circulation.母血循环中游离胎儿核酸识别标志物
Adv Biomed Res. 2017 Jul 28;6:89. doi: 10.4103/2277-9175.211800. eCollection 2017.
2
[Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].游离胎儿DNA在母体血浆中用于无创产前诊断的临床应用
Zhonghua Fu Chan Ke Za Zhi. 2012 Nov;47(11):813-7.
3
Cell-free fetal nucleic acids in amniotic fluid.羊水的无细胞胎儿核酸。
Hum Reprod Update. 2011 May-Jun;17(3):362-71. doi: 10.1093/humupd/dmq049. Epub 2010 Oct 5.
4
Noninvasive prenatal diagnosis of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis.通过母体血浆核酸分析对胎儿染色体非整倍体进行无创产前诊断。
Clin Chem. 2008 Mar;54(3):461-6. doi: 10.1373/clinchem.2007.100016. Epub 2008 Jan 17.
5
Noninvasive prenatal diagnosis of aneuploidy using cell-free nucleic acids in maternal blood: promises and unanswered questions.利用母血中游离核酸进行非整倍体的无创产前诊断:前景与未解决的问题
Prenat Diagn. 2008 Jan;28(1):1-6. doi: 10.1002/pd.1902.
6
Fetal nucleic acids in maternal body fluids: an update.母体内液体中的胎儿核酸:最新进展
Ann N Y Acad Sci. 2006 Sep;1075:63-73. doi: 10.1196/annals.1368.008.
7
A Method to Quantify Cell-Free Fetal DNA Fraction in Maternal Plasma Using Next Generation Sequencing: Its Application in Non-Invasive Prenatal Chromosomal Aneuploidy Detection.一种利用下一代测序技术定量母体血浆中游离胎儿DNA比例的方法:其在无创产前染色体非整倍体检测中的应用
PLoS One. 2016 Jan 14;11(1):e0146997. doi: 10.1371/journal.pone.0146997. eCollection 2016.
8
Fetal RHD detection from circulating cell-free fetal DNA in maternal plasma: validation of a diagnostic kit using automatic extraction and frozen DNA.从母体血浆中循环游离胎儿DNA检测胎儿RHD:使用自动提取和冷冻DNA的诊断试剂盒的验证
Transfus Med. 2019 Dec;29(6):408-414. doi: 10.1111/tme.12605. Epub 2019 Jun 17.
9
Placental volume, as measured by 3-dimensional sonography and levels of maternal plasma cell-free fetal DNA.通过三维超声测量的胎盘体积以及母体血浆游离胎儿DNA水平。
Am J Obstet Gynecol. 2005 Aug;193(2):496-500. doi: 10.1016/j.ajog.2004.12.015.
10
Noninvasive Diagnosis of Fetal Gender: Utility of Combining DYS14 and SRY.胎儿性别的非侵入性诊断:DYS14与SRY联合应用的效用
Genet Test Mol Biomarkers. 2015 Sep;19(9):505-11. doi: 10.1089/gtmb.2015.0040. Epub 2015 Jun 29.

引用本文的文献

1
Nanostructures in non-invasive prenatal genetic screening.无创产前基因检测中的纳米结构
Biomed Eng Lett. 2021 Oct 11;12(1):3-18. doi: 10.1007/s13534-021-00208-6. eCollection 2022 Feb.
2
Assessment of Fetal Rhesus D and Gender with Cell-Free DNA and Exosomes from Maternal Blood.采用母体外周血游离 DNA 和外泌体评估胎儿 RhD 血型和性别。
Reprod Sci. 2021 Feb;28(2):562-569. doi: 10.1007/s43032-020-00321-4. Epub 2020 Sep 23.
3
Circulating Cell-Free Nucleic Acids as Epigenetic Biomarkers in Precision Medicine.循环游离核酸作为精准医学中的表观遗传生物标志物

本文引用的文献

1
Overview of Five-Years of Experience Performing Non-Invasive Fetal Sex Assessment in Maternal Blood.母体血液中无创伤性胎儿性别评估五年经验概述。
Diagnostics (Basel). 2013 May 15;3(2):283-90. doi: 10.3390/diagnostics3020283.
2
Detection of paternally inherited fetal point mutations for β-thalassemia in maternal plasma using simple fetal DNA enrichment protocol with or without whole genome amplification: an accuracy assessment.使用简单的胎儿DNA富集方案(有无全基因组扩增)检测母血中父源遗传的胎儿β地中海贫血点突变:准确性评估
J Matern Fetal Neonatal Med. 2016;29(16):2645-9. doi: 10.3109/14767058.2015.1095883. Epub 2015 Nov 9.
3
Front Genet. 2020 Aug 11;11:844. doi: 10.3389/fgene.2020.00844. eCollection 2020.
4
Circulating RNA Transcriptome of Pregnant Women with TSH Just Above the Trimester-Specific Reference and its Correlation with the Hypertensive Phenotype.孕妇 TSH 略高于孕期特异性参考值的循环 RNA 转录组及其与高血压表型的相关性。
Sci Rep. 2020 Apr 15;10(1):6439. doi: 10.1038/s41598-020-63040-5.
Circulating microRNAs as clinical biomarkers in the predictions of pregnancy complications.
循环微RNA作为预测妊娠并发症的临床生物标志物。
Biomed Res Int. 2015;2015:294954. doi: 10.1155/2015/294954. Epub 2015 Jan 29.
4
Review: placenta-specific microRNAs in exosomes - good things come in nano-packages.综述:外泌体中的胎盘特异性微小RNA——纳米包裹中的有益物质。
Placenta. 2014 Feb;35 Suppl:S69-73. doi: 10.1016/j.placenta.2013.11.002. Epub 2013 Nov 15.
5
Maternal plasma miRNAs expression in preeclamptic pregnancies.子痫前期妊娠中母体血浆微小RNA的表达
Biomed Res Int. 2013;2013:970265. doi: 10.1155/2013/970265. Epub 2013 Sep 9.
6
MicroRNAs in Human Placental Development and Pregnancy Complications.人类胎盘发育和妊娠并发症中的 microRNAs。
Int J Mol Sci. 2013 Mar 8;14(3):5519-44. doi: 10.3390/ijms14035519.
7
Placental expression of microRNA-17 and -19b is down-regulated in early pregnancy loss.胎盘组织中 microRNA-17 和 -19b 的表达在早期妊娠丢失中下调。
Eur J Obstet Gynecol Reprod Biol. 2013 Jul;169(1):28-32. doi: 10.1016/j.ejogrb.2013.01.025. Epub 2013 Feb 20.
8
Diagnostic potential for miRNAs as biomarkers for pregnancy-specific diseases.miRNAs 作为妊娠特有疾病生物标志物的诊断潜力。
Clin Biochem. 2013 Jul;46(10-11):953-60. doi: 10.1016/j.clinbiochem.2013.01.026. Epub 2013 Feb 7.
9
Non-invasive prenatal diagnosis using cell-free fetal nucleic acids in maternal plasma: Progress overview beyond predictive and personalized diagnosis.利用母体血浆中的游离胎儿核酸进行无创性产前诊断:超越预测性和个体化诊断的进展概述。
EPMA J. 2011 Jun;2(2):163-71. doi: 10.1007/s13167-011-0085-y. Epub 2011 May 17.
10
Evaluation of a novel assay for detection of the fetal marker RASSF1A: facilitating improved diagnostic reliability of noninvasive prenatal diagnosis.评估一种新型检测胎儿标志物 RASSF1A 的方法:提高非侵入性产前诊断的诊断可靠性。
PLoS One. 2012;7(9):e45073. doi: 10.1371/journal.pone.0045073. Epub 2012 Sep 14.